Clinicopathological features of gastric cancer detected by endoscopy as part of annual health checkup

Abstract

Background and Aim: Upper gastrointestinal endoscopy is generally accepted as the gold standard for the clinical evaluation of gastric cancer (GC). However, the efficacy of endoscopic screening for asymptomatic GC remains controversial. The present study is designed to clarify the efficacy of endoscopic screening for the detection of early GC by investigating the clinicopathological features. Methods: A total of 17 522 patients who had underwent endoscopic screening as a part of their annual health checkup at the Seirei Center for Health Promotion and Preventive Medicine between April 2002 and March 2006 were enrolled in this study. We investigated the clinicopathological findings of GC detected by endoscopy. Furthermore, in accordance with the screening interval at our center, patients with GC were categorized into two groups: group A, patients with repeated endoscopic screening within the last 2 years, and group B, patients without endoscopic screening within the last 2 years. Results: Thirty-nine GC (mean age of patients: 62.2 Ϯ 8.0 years, 36 males and three females) were detected in total (0.22%). The proportion of early GC was 87.2%. Notable differences between groups A and B were not found in the rate of early GC (P = 0.6342). However, eight of 27 cases (29.6%) in group A were treated by endoscopic resection, but none in group B (P = 0.0344). In six of 26 cases (23.1%) in group A, the recorded images from the previous endoscopic examination indicated some macroscopic abnormalities at the same location, suggesting GC or premalignant lesions. Conclusion: Endoscopic screening is useful for detecting GC at the early stages, and repeated examinations at short-time intervals contribute to the detection of resectable lesions by endoscopy. Further studies are needed to decrease the false negative rate of endoscopic screening.

Risk Factors of Developing Interval Early Gastric Cancer After Negative Endoscopy

“…However, the rate of false-negative results associated with the detection of gastric cancer via endoscopy was higher than expected, and endoscopic diagnosis of EGC is difficult because often only subtle changes occur, which are not observed on endoscopic examination. Hosokawa et al [15] reported that the rate of false-negative results for the detection of EGC while using gastroscopy was 25.8 % at 3 years, and Aida et al [16] reported that endoscopic screening identified six of 26 gastric cancer (23.1 %) as missed lesion on previous endoscopy.…”

Nodal Counts on MDCT as a Surrogate Marker for Surgical Curability in Gastric Cancer

“…1 Even now, however, some patients are detected with advanced-stage disease. During gastrectomy for advanced gastric cancers, it is important to diagnose surgical curability and to avoid excessive surgery, which is a risk factor for complications and has the potential to decrease survival.…”

New method for detection of gastric cancer by hyperspectral imaging: a pilot study

“…Such cancers are often missed by EGD; the reported miss rate for gastric cancers is approximately 20%. 4 Although image-enhanced endoscopic technologies such as narrow-band imaging (NBI) 5 and flexible spectral imaging color enhancement (FICE) 6 have been developed, they are not sufficient to improve the detection rate of gastric cancers.…”